公开(公告)号：WO9309791A3

公开(公告)日：1993-06-24

申请号：PCT/FR9201056

申请日：1992-11-13

Applicant: MAYOLY SPINDLER LAB ,  SEMAN MICHEL

Inventor： SEMAN MICHEL

IPC: C07H17/08 ,  A61K31/70 ,  A61K31/7042 ,  A61K31/7048 ,  A61P31/12 ,  A61P43/00 ,  C07D407/12 ,  A61K31/71

CPC classification number: A61K31/7048

Abstract: Novel utilisation of amphotericin B, or a derivative thereof, as protease inhibitor. Application to the production of medicaments inhibiting the multiplication of pathogenic agents, particularly HIV.

公开(公告)号：WO2008107533A2

公开(公告)日：2008-09-12

申请号：PCT/FR2008000040

申请日：2008-01-15

Applicant: MAYOLY SPINDLER LAB ,  CRITON MARC ,  LEMELLAY HAMON VERONIQUE ,  LEBLOND YVES

Inventor： CRITON MARC ,  LEMELLAY HAMON VERONIQUE ,  LEBLOND YVES

IPC: A61K38/08

CPC classification number: A61K31/375 ,  A61K8/64 ,  A61K8/675 ,  A61K8/676 ,  A61K31/455 ,  A61K38/08 ,  A61K2800/70 ,  A61K2800/782 ,  A61Q19/02 ,  A61K2300/00

Abstract: The invention relates to an association including at least : a MC1-R receptor inhibitor; a tyrosinase inhibitor derived from vitamin C; an inhibitor of the transfer of melanosomes to the keratinocytes; the invention also relates to the use thereof in cosmetics and dermatology for preparing whitening and/or bleaching depigmentation compositions.

Abstract translation: 本发明涉及至少包括：MC1-R受体抑制剂; 来自维生素C的酪氨酸酶抑制剂; 黑素体转运至角化细胞的抑制剂; 本发明还涉及其在化妆品和皮肤病学中用于制备增白和/或漂白脱色组合物的用途。

公开(公告)号：WO2004011444A3

公开(公告)日：2004-04-08

申请号：PCT/FR0302341

申请日：2003-07-24

Applicant: MAYOLY SPINDLER LAB ,  CENTRE NAT RECH SCIENT ,  UNIV MONTPELLIER II ,  GLOUX DAMIEN ,  CRITON MARC ,  MONTERO JEAN-LOUIS

Inventor： GLOUX DAMIEN ,  CRITON MARC ,  MONTERO JEAN-LOUIS

IPC: A61K31/42 ,  A61P1/04 ,  A61P9/00 ,  A61P11/06 ,  A61P17/02 ,  A61P17/06 ,  A61P19/02 ,  A61P29/00 ,  A61P37/08 ,  A61P43/00 ,  C07D231/10 ,  C07D261/08 ,  C07D275/02

CPC classification number: C07D261/08 ,  C07D231/10 ,  C07D275/02

Abstract: The invention concerns a method for synthesizing styryl isoxazole, styryl pyrazole and styryl isothazole derivatives in a synthesis step followed by a recrystallization in a basic alcohol medium.

Abstract translation: 本发明涉及在合成步骤中合成苯乙烯基异恶唑，苯乙烯基吡唑和苯乙烯基
异噻唑衍生物，接着在碱性醇介质中重结晶的方法。